Advanced peptide science, bioregulators, and applied clinical protocol training, developed in collaboration with the American Academy of Peptide Medicine.
Program approval and authorization provided by Dr. Pradeep Albert, Chief Medical Officer, American Academy of Peptide Medicine.
A dedicated two-day certification component inside The Regenerative Frontier, built for clinicians who intend to prescribe. The curriculum moves from mechanism to protocol: how these compounds signal, where they act, how to select and sequence them, and how to monitor a patient once therapy begins.
The OMNI RMETI Peptide and Bioregulator Program is being developed in collaboration with the American Academy of Peptide Medicine (AAPM). Program approval and authorization have been provided by Dr. Pradeep Albert, Chief Medical Officer of the American Academy of Peptide Medicine.
The program combines advanced peptide science, bioregulators, regenerative medicine, longevity, mitochondrial medicine, neuro-restoration, metabolic optimization, and practical clinical protocol education.
Join the faculty on site at the OMNI Surgery Center in Utica, New York, alongside the wider Regenerative Frontier intensive.
Both days are professionally recorded. Attend either day live or by recording, with no requirement to be present for a specific session.
A certificate of completion is issued on finishing the two-day program. Certificate requirements are confirmed on enrollment.
Teaching is organized by subject expertise rather than by assigning one lecturer per day. Faculty move across the curriculum according to specialty, with protocol, application, and case-based sessions running throughout.
Individual lecture titles and the day-by-day running order are confirmed with the final program schedule.
Peptide science and bioregulator content is led by faculty who have spent their careers inside it. Clinical and specialty faculty join throughout for protocol design, application, and case-based sessions.
One of the world's leading authorities on peptides and, after Dr. Khavinson, the current godfather of peptide science. Academic training spanning exercise physiology, biochemistry, and pharmacology. Researching peptides since the late 1990s. Leads the peptide science, signaling, mitochondrial biology, longevity, performance, and recovery content.
Functional nutritionist and precision medicine coach working in ketogenic protocols, gut health, peptides, and bio-regulators. Teaches the bioregulator and applied nutrition content, and contributes to protocol design and case-based sessions across both days.
McGill-trained neurointerventional specialist in cerebrovascular regeneration, photobiomodulation, autonomic restoration, and executive cognitive longevity medicine. Contributes to protocol design and case-based sessions across both days.
Founder, Eterna Health. Pioneer in stem cells, peptide protocols, and gene-therapy-adjacent biologic platforms. Treats elite athletes across four continents. Leads clinical application and combination-protocol sessions.
Founder, Rachel Clinic, Las Vegas. AGACNP with ICU leadership across the Middle East and the United States. Focuses on IV infusion, peptide recovery, and clinical workflow design.
Founder, The Resurge Clinic, Weatherford, Texas. Board-certified family physician certified in age management medicine. Certified in peptide therapy since 2015 through the International Peptide Society and SSRP, and SSRP faculty since 2022. Medical director of the BioTe Training Clinic in Irving, Texas, and a global lecturer on hormones and peptides.
The Peptide and Bioregulator Certification is included in the full Regenerative Frontier program, and is also available on its own.
Tell us about your practice and our team will follow up within 48 hours to confirm eligibility, enrollment, and scheduling. You can also reach us anytime at info@omnirmeti.com.
Accreditation. The OMNI RMETI Peptide and Bioregulator Program is being developed in collaboration with the American Academy of Peptide Medicine (AAPM). AAPM approval and CME accreditation are separate matters. This program does not represent CME approval. CME accreditation is being explored, and any change in status will be communicated directly to enrolled participants.
Scope. This program is professional education for practitioners. It is not a board certification program, and it does not confer a license, a specialty designation, or authority to practice beyond a participant's existing scope. Nothing on this page is medical advice or a treatment recommendation.
Clinical claims. Many peptide and bioregulator compounds discussed in this curriculum are not FDA approved for the indications covered, and regulatory status varies by compound and jurisdiction. No statement here should be read as a claim of safety, efficacy, or clinical outcome. Prescribing decisions remain the responsibility of the treating clinician.
Program details. Dates, session times, individual lecture titles, and certificate requirements are confirmed with the final program schedule and communicated to enrolled participants.